SCHEMBL9997185

SCHEMBL9997185

CC/C(=C\c1ccccc1Cl)C(OC(C)=O)OC(C)=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.45
LMNA P02545 1/20 0.45
HPGD P15428 1/20 0.45
NOS2 P35228 4/20 0.43
NOS3 P29474 3/20 0.43
NOS1 P29475 3/20 0.43
HDAC1 Q13547 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
TRPA1 O75762 1/20 0.38
MAPT P10636 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
MAOB P27338 3/20 0.37
ALDH1A1 P00352 1/20 0.36
POLB P06746 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
CA1 P00915 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9997186 1.00 SMN1; SMN2 (0.45) SMN1; SMN2LMNAHPGDNOS2NOS3
SCHEMBL9998029 0.89 SMN1; SMN2 (0.43) SMN1; SMN2LMNAHPGDNOS2NOS3
SCHEMBL9998031 0.89 SMN1; SMN2 (0.43) SMN1; SMN2LMNAHPGDNOS2NOS3
SCHEMBL9997363 0.85 LMNA (0.45) SMN1; SMN2LMNAHPGDNOS2NOS3
SCHEMBL9997364 0.85 LMNA (0.45) SMN1; SMN2LMNAHPGDNOS2NOS3
SCHEMBL9997823 0.84 ALDH1A1 (0.38) SMN1; SMN2LMNAHPGDHDAC1HDAC8
SCHEMBL9997859 0.84 KCNH2 (0.34) LMNANOS2NOS3NOS1HDAC1
SCHEMBL9997822 0.84 ALDH1A1 (0.38) SMN1; SMN2LMNAHPGDHDAC1HDAC8
SCHEMBL9997860 0.84 KCNH2 (0.34) LMNANOS2NOS3NOS1HDAC1
SCHEMBL9997886 0.83 HDAC1 (0.41) SMN1; SMN2LMNAHPGDNOS2NOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 SMN1; SMN2 3151/4885LMNA 3752/4885HPGD 1450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.